February 17, 2021 Talis Announces Closing of Initial Public Offering and
Talis Announces Closing of Initial Public Offering and
Full Exercise of Underwriters’ Option to Purchase Additional Shares
MENLO PARK, CALIF., Wednesday, February 17, 2021 – Talis Biomedical Corporation (Nasdaq: TLIS), a company…